Diffusion captures pocket motion; RL boosts syn. hit rate 6×

Today's Overview

  • Diffusion model jointly generates ligand topology and pocket flexibility Joint diffusion of pocket coordinates and ligand atom types captures induced-fit effects missing in rigid-pocket generators.
  • SynthSense RL Rewards Route Coherence, Yielding 6.2× More Synthetically Feasible Hits Reinforcement learning with retrosynthetic rewards increases synthetically feasible hit generation 6.2-fold over unconstrained models.
  • Open-source docking and AI tools converge into practical, end-to-end hit-finding pipelines Open-source docking ecosystem now covers the full SBDD workflow from data acquisition to post-docking validation, lowering cost barriers for early hit identification.

Also Worth Noting

04
Target context helps only when architecture and data matchADMET & Properties

A systematic 10-family, 67–9,409-compound study shows FiLM-based target conditioning lifts AUC from 0.238 to 0.686 in data-scarce CYP3A4 yet drops 10.2 pp on BACE1 under distribution shift, while exposing leakage that lets 1-NN Tanimoto hit 0.991 on DUD-E. link (Science)

Today's Observation

Across the three papers, generative and screening SBDD tools are maturing in silico but remain untested at the bench. Papers 1 and 2 both train diffusion or RL models to satisfy downstream criteria—induced-fit docking energies in the first, retrosynthetic accessibility and plate-level coherence in the second—and report purely computational success metrics (AutoDock scores comparable to native ligands; 6.2-fold more “synthetically feasible” hits and 4× more fillable plates). None of the designed molecules have been synthesized or assayed, so affinity, yield, and activity remain unknown.

Paper 3 contextualizes the gap: open-source docking/AI pipelines now cover hit-finding end-to-end, embedding pose prediction and rescoring, yet the community still lacks unified benchmarks and standardized preparation steps. Practitioners should treat the reported energy or feasibility gains as useful filters, not guarantees, and plan for in vitro validation before declaring either flexible-pocket diffused ligands or RL-optimized routes as real progress.

The above is personal commentary for reference only. Refer to the original papers for authoritative content.